# Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial

> **NCT02055872** · PHASE3 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 46 (actual)

## Conditions studied

- Edema
- Hypoproteinemia

## Interventions

- **DRUG:** Intravenous albumin
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02055872
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055872, "Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02055872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*